Efficacy of Trovafloxacin in Treatment of Experimental Staphylococcal or Streptococcal Endocarditis
The efficacy of trovafloxacin against Staphylococcus aureus and viridans group streptococci was investigated in vitro and in an experimental model of endocarditis. The MICs at which trovafloxacin and ciprofloxacin inhibited 90% of clinical isolates of such bacteria (MIC(90)s) were (i) 0.03 and 2 mg/...
Сохранить в:
| Опубликовано в:: | Antimicrob Agents Chemother |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology (ASM)
1999
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89024/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9869569/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.1.77 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|